The way we have looked at pricing at Merck is we've always said we want to be responsible, which means we want to optimize profitability and patient access.
I am a person who does not subscribe to the hero-CEO school of thought.
I'm the last senior executive who was hired by Roy Vagelos. It's an honor, but it also imposes upon me an obligation not only to think about his legacy but also about this company's legacy.
One of the strongest forms of rhetoric in our society is the rhetoric of blame.
I think if you look at Merck's history, I think Merck has a reputation for having been a reasonable company when it comes to pricing, sort of a leader in that respect.
Competition in our health system is a powerful force of cost-containment.
